LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H (HK:2291) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
LEPU ScienTech Medical Technology has renewed its agreements with Lepu Medical, reinforcing its ongoing clinical trial, parts purchase, and product sales operations. These transactions, categorized as continuing connected transactions under Hong Kong’s listing rules, require reporting and shareholder approval. An Extraordinary General Meeting (EGM) will be held for shareholders to vote on these agreements.
For further insights into HK:2291 stock, check out TipRanks’ Stock Analysis page.